Study: COVID-19 convalescent plasma unlikely to benefit certain ED patients

by on

Study: COVID-19 convalescent plasma unlikely to benefit certain ED patients
tjordan_drupal
Mar 2, 2021

The National Institutes of Health has halted a clinical trial evaluating the effectiveness of COVID-19 convalescent plasma in emergency department patients with mild-to-moderate COVID-19 symptoms and at least one risk factor for severe COVID-19 after an independent board concluded from the data that the treatment was unlikely to help such patients.

Forty-seven U.S. hospital EDs were participating in the study, which found no significant difference in outcomes for participants who received COVID-19 convalescent plasma or a placebo.

Headline

Study: COVID-19 convalescent plasma unlikely to benefit certain ED patients
tjordan_drupal
Mar 2, 2021

The National Institutes of Health has halted a clinical trial evaluating the effectiveness of COVID-19 convalescent plasma in emergency department patients with mild-to-moderate COVID-19 symptoms and at least one risk factor for severe COVID-19 after an independent board concluded from the data that the treatment was unlikely to help such patients.

Forty-seven U.S. hospital EDs were participating in the study, which found no significant difference in outcomes for participants who received COVID-19 convalescent plasma or a placebo.

COVID-19: Vaccines and Therapeutics
Novel Coronavirus (SARS-CoV-2/COVID-19)
Emergency Departments (EDs)

Headline

VA:F [1.9.7_1111]
Rating: 0.0/10 (0 votes cast)
VA:F [1.9.7_1111]
Rating: 0 (from 0 votes)

Leave a Comment

Previous post:

Next post: